PE firm continues investments in health care industry by taking a stake in Jaggaer

By Maggie Lynch

- Last updated on GMT

(Image: Getty/FeelPic)
(Image: Getty/FeelPic)

Related tags PE Investment Health care Software Medpace Bioclinica acquistion

The strategic sourcing software company Jaggaer has received an investment from international PE firm Cinven.

Cinven will support Jaggaer’s management and operations as it plans to increase assets and capabilities in its spend management suite, The Jaggaer One platform.

According to Jaggaer, the platform uses machine learning and artificial intelligence (AI) capabilities in its network of 4m suppliers to simplify the contracting process for clients taking on existing and potential customers.

Chris Good, partner and co-head of Cinven’s technology, media, and telecom (TMT) team, said in a statement, “As a growing and profitable spend management software business with a very strong track record, and following a number of successful acquisitions, the business is poised for continued significant growth.”

No financial terms of this investment were disclosed.

The UK-based private equity (PE) company has raised a total of €37bn and invested in 135 companies across Europe and North America. The investment in Jaggaer follows investments in Medpace​ in 2014 and Bioclinica​ in 2016.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us


View more